IHS Chemical Week

People & Business :: M&A

Merck KGaA eyes pharma acquisitions in the US; strengthens ties with Israeli firms

2:05 PM MST | November 26, 2013 | Natasha Alperowicz in Yavne and Rehovot, Israel

Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and acquisitions. At today’s press briefing in Yavne, Israel, the location of Merck Serono’s subsidiary in Israel, Stefan Oschmann, board member Merck KGaA/pharma and consumer health, said that the average global pharma company generates about 50% of its sales in the US while Merck’s share is only 20%. He said that Merck is planning to raise this soon and that may include...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa